Clindamycin Phosphate NDC 73473-302

NDC codes

FDA NDC Directory

Product NDC (as listed)73473-302Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73473-0302Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73473-302-75	73473030275	1 BOTTLE in 1 CARTON (73473-302-75) / 75 mL in 1 BOTTLEMarketed from Sep 15, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 1 g/10mL
Dosage form: Gel
Route: Topical
Labeler: Solaris Pharma Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212842
Marketing start: Sep 15, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 73473-302_3a42199c-8c43-4fe7-83fc-4dd5af82279dSPL ID 3a42199c-8c43-4fe7-83fc-4dd5af82279dSPL set ID fde07866-b012-47ad-932e-b76f141f86eeUNII EH6D7113I8UPC 0373473302750
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473473030275 followed by a unit qualifier and the quantity

Package 73473-0302-75. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 13, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin phosphate gel, 1% is indicated for topical application in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea, and pseudomembranous colitis, the physician should consider whether other agents are more appropriate. (See CONTRAINDICATIONS , WARNINGS , and ADVERSE REACTIONS .)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)